July 25 (Reuters) - Sanofi's CFO

Francois-Xavier Roger said on Thursday that the company was

reviewing potential scenarios for the separation of its consumer

health unit, including a sale or a listing, but no decision has

been made.

The French drugmaker expects to make a decision in the next

few months, Roger told reports after the release of its

second-quarter results, with the separation on track by the

fourth quarter of 2024 at the earliest